Bottom line
How much do FBDIX and RYOIX overlap?
45% of their top holdings overlap by weight. 12 securities appear in both funds' top 25, making up 37.3% of FBDIX's assets and 29.9% of RYOIX's. They share a meaningful core but differ in the rest of the portfolio.
Updated Nov 22, 2026
Overlap at a glance
Holdings FBDIX and RYOIX have in common
| Holding | % of FBDIX | % of RYOIX | Overlap |
|---|---|---|---|
| Jazz Pharmaceuticals plc | 5.66% | 1.42% | 1.42% |
| Amgen, Inc. | 4.39% | 5.05% | 4.39% |
| Gilead Sciences, Inc. | 3.86% | 4.49% | 3.86% |
| Regeneron Pharmaceuticals, Inc. | 3.77% | 2.93% | 2.93% |
| Argenx SE | 3.62% | 1.48% | 1.48% |
| Vertex Pharmaceuticals, Inc. | 3.54% | 4.32% | 3.54% |
| Revolution Medicines, Inc. | 3.01% | 2.48% | 2.48% |
| Guardant Health, Inc. | 2.76% | 1.72% | 1.72% |
| Insmed, Inc. | 1.99% | 1.79% | 1.79% |
| Neurocrine Biosciences, Inc. | 1.82% | 1.52% | 1.52% |
| Bridgebio Pharma, Inc. | 1.67% | 1.38% | 1.38% |
| Cytokinetics, Inc. | 1.24% | 1.35% | 1.24% |
Source: SEC Form N-PORT (periods Jul 31, 2026 / Jun 30, 2026)
Free weekly newsletter
The Fund Letter
Get fee cuts and hikes, fund closures and mergers, and one plain-English idea to make your portfolio cheaper — every week.
Free. Unsubscribe anytime. We never sell your email.
What each fund holds that the other doesn't
Top-25 holdings that appear in only one of the two funds' top 25.
Only in FBDIX
- Franklin Institutional U.S. Government Money Market Fund — 3.18%
- Ascendis Pharma A/S — 2.56%
- Dianthus Therapeutics, Inc. — 2.32%
- Mirum Pharmaceuticals, Inc. — 1.98%
- Praxis Precision Medicines, Inc. — 1.91%
- Spyre Therapeutics, Inc. — 1.87%
- Oruka Therapeutics, Inc. — 1.86%
- PTC Therapeutics, Inc. — 1.65%
- AstraZeneca plc — 1.51%
- Franklin Institutional U.S. Government Money Market Fund — 1.45%
- Amylyx Pharmaceuticals, Inc. — 1.32%
- Eli Lilly & Co. — 1.31%
- Tango Therapeutics, Inc. — 1.23%
Only in RYOIX
- Abbvie Inc — 8.17%
- Alnylam Pharmaceuticals Inc — 2.36%
- Beone Medicines Ltd — 2.17%
- Moderna Inc — 2.15%
- Biogen Inc — 2.13%
- Natera Inc — 2.12%
- Royalty Pharma Plc — 2.01%
- Illumina Inc — 1.94%
- United Therapeutics Corp — 1.72%
- Roivant Sciences Ltd — 1.66%
- Incyte Corp — 1.62%
- Viatris Inc — 1.55%
- Ionis Pharmaceuticals Inc — 1.35%
Asset mix
| Asset type | FBDIX | RYOIX |
|---|---|---|
| Stocks | 97.0% | 99.6% |
| Cash & short-term funds | 4.6% | 0.6% |
| Preferred stock | 1.0% | — |
| Other | 0.6% | — |
| Repurchase agreements | — | 0.6% |
Source: SEC Form N-PORT (periods Jul 31, 2026 / Jun 30, 2026)
Country mix
| Country | FBDIX | RYOIX |
|---|---|---|
| US | 82.0% | 85.8% |
| IE | 6.7% | 2.7% |
| NL | 4.5% | 1.5% |
| CH | 1.2% | 3.3% |
| GB | 1.5% | 3.2% |
| DK | 2.6% | 0.9% |
| FR | 1.7% | — |
| BM | — | 1.7% |
Source: SEC Form N-PORT (periods Jul 31, 2026 / Jun 30, 2026)
Check another pair
FAQ
How much do FBDIX and RYOIX overlap?
What stocks do FBDIX and RYOIX have in common?
Should I own both FBDIX and RYOIX?
Which holds more stocks, FBDIX or RYOIX?
Overlap is computed from each fund's top 25 holdings in its latest SEC Form N-PORT filing, with weights normalized to the top 25; for each shared security we count the smaller of the two weights. Educational information, not investment advice.